Disability

American Disabilities Testing Association Expands LSAT Accommodations Services for Candidates with Anxiety-Related Conditions with the Launch of LSATaccommodations.com

New evaluations support LSAT extended time, additional breaks, and remote testing requests for law school applicants MIAMI, FL / ACCESS...

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...

Shore Medical Center First in New Jersey to offer the VELYS™ Active Robotic Assistance Technology for Spinal Procedures

Next generation, dual-use robotics and navigation platform allows for surgical guidance tailored to surgeon preference and the patient SOMERS POINT,...

The National Paralysis Resource Center, operated by the Christopher & Dana Reeve Foundation, Announces Last Quality of Life Grants Program Awardees as Part of Current Federal Funding Cycle

The National Paralysis Resource Center, operated by the Christopher & Dana Reeve Foundation, Announces Last Quality of Life Grants Program Awardees as Part of Current Federal Funding Cycle

Caregivers in Crisis: New Survey from Aeroflow Urology Reveals 77% of Caregivers are Drowning in Costs as Out-of-Pocket Expenses Reach a Breaking Point

A crisis across the country is brewing as 57% of respondents report having to reduce their work hours to provide...

PopSockets Launches Phone Better, a Year‑Long Initiative Inspired by New Research with Harris Poll on Accessibility and Everyday Phone Design

PopSockets Introduces the Initiative to Champion More Inclusive, Comfortable Phone Experiences NEW YORK, June 22, 2026 /PRNewswire/ -- PopSockets, the original phone...

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time...

Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief

CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc...

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Builds on positive Phase I safety data and represents a key value-inflection milestone for the CompanyAdvances a potentially disease-modifying approach...

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today...

error: Content is protected !!